TD Securities (USA)’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-113,122
Closed -$24M 532
2014
Q4
$24M Buy
113,122
+9,170
+9% +$1.82M 0.34% 68
2014
Q3
$18.5M Sell
103,952
-68
-0.1% -$11.3K 0.3% 80
2014
Q2
$17.6M Buy
104,020
+6,075
+6% +$946K 0.28% 88
2014
Q1
$12.2M Sell
97,945
-6,897
-7% -$840K 0.22% 113
2013
Q4
$11.6M Buy
104,842
+3,217
+3% +$307K 0.2% 128
2013
Q3
$9.19M Buy
101,625
+561
+0.6% +$50.4K 0.18% 135
2013
Q2
$8.51M Buy
+101,064
New +$10.5M 0.17% 135

Other funds holding AGN

TD Securities (USA)'s AGN Position: Q1 2015 in Review

TD Securities (USA) sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 113,122 shares — an estimated $24M sold.

TD Securities (USA) first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $24M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • TD Securities (USA) reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • TD Securities (USA) sold 113,122 Allergan Inc shares in Q1 2015, an estimated $24M.
  • TD Securities (USA) first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • TD Securities (USA)'s Allergan Inc position peaked at $24M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on TD Securities (USA)'s 13F filing for Q1 2015, filed 27 Apr 2015.